🔎 Trials Near Me

Akèy › Timè nan sèvo › Tennessee › Nashville

Etid klinik pou Timè nan sèvo nan Nashville, TN

8 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
  • Sarah Canon Research Institute (SCRI) Oncology Partners, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Ap rekriteFaz 1
  • SCRI Oncology Partners, Nashville
  • Vanderbilt Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Ap rekriteFaz 1/2
  • SCRI Oncology Partners, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05386108

Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Ap rekriteFaz 1 bonè
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT07210632

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Ap rekriteFaz 1 bonè
  • Vanderbilt University Medical Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT07493447

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Vanderbilt-Ingram Cancer Center, Nashville
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Ap rekriteFaz 1 bonè
  • Vanderbilt University/Ingram Cancer Center, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2024 · NCT05996432

Etid Timè nan sèvo nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.